The latest price target for Phibro Animal Health (NASDAQ:PAHC) was reported by Morgan Stanley on December 17, 2024. The analyst firm set a price target for $25.00 expecting PAHC to rise to within 12 months (a possible 15.26% upside). 5 analyst firms have reported ratings in the last year.

The latest analyst rating for Phibro Animal Health (NASDAQ:PAHC) was provided by Morgan Stanley, and Phibro Animal Health maintained their equal-weight rating.

The last upgrade for Phibro Animal Health Corp happened on January 10, 2022 when Barclays raised their price target to $23. Barclays previously had an underweight for Phibro Animal Health Corp.

The last downgrade for Phibro Animal Health Corp happened on July 25, 2022 when Barclays changed their price target from N/A to $22 for Phibro Animal Health Corp.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Phibro Animal Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Phibro Animal Health was filed on December 17, 2024 so you should expect the next rating to be made available sometime around December 17, 2025.

While ratings are subjective and will change, the latest Phibro Animal Health (PAHC) rating was a maintained with a price target of $20.00 to $25.00. The current price Phibro Animal Health (PAHC) is trading at is $21.69, which is within the analyst’s predicted range.